Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 5857 - 5864 of 12003 results

Are Third-Party Funding Costs Recoverable in Arbitration?

July 23, 2018| Blog| Viewpoint

The Four Things You Need To Know About The Future of Energy Efficiency

July 23, 2018| Blog| Viewpoint

CMS Focuses on a Modern Medicare

July 23, 2018| Blog| Viewpoint

ML Strategies Weekly Health Care Preview – July 23, 2018

July 23, 2018| Blog| Viewpoint

CMS Proposes to Reduce Payments for New Drugs under Medicare Part B

July 20, 2018| Blog| Viewpoint

Does USCIS Want to Turn Lawful Immigrants into Unlawful, Removable Immigrants? The Answer it seems, is “Yes”

July 20, 2018| Blog| Viewpoint

With its Vanda Pharma and Berkheimer Memos, USPTO Provides Increased Clarity and Predictability in the Patent Eligibility Determination in a Further Boost for Stakeholders and Innovators in Personalized Medicine

July 19, 2018| Advisory| Viewpoint

Special Master Recommends Return of $10.6 Million in Attorneys’ Fees to Class Members

July 19, 2018| Blog| Viewpoint

News & Press Releases

Mintz Advises Syntis Bio on $33 Million Series A Financing

July 02, 2025

Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.

Mintz Obtains Trademark TRO Against OpenAI on Behalf of IYO, Inc.

June 30, 2025

Mintz secured a rare trademark temporary restraining order (TRO) on behalf of IYO, Inc. against OpenAI, Sam Altman, Sir Jony Ive, and IO Products, Inc. The order temporarily bars the defendants from using the trademark associated with their new product launch.

Mintz Advises Brij in $8M Oversubscribed Funding Round

June 26, 2025

Mintz advised Brij—a software platform enhancing the consumer experience by bridging online and offline commerce—on the closing of its $8 million Series Seed round. The funding will help Brij advance its mission to close the trillion-dollar disconnect between brands and their retail customers and power the next generation of offline-to-online customer relationships.

View all News and Press Releases